Israel Englander’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-777,952
| Closed | -$4.75M | – | 7804 |
|
|
2021
Q3 | $4.75M | Buy |
777,952
+202,906
| +35% | +$1.26M | ﹤0.01% | 2922 |
|
|
2021
Q2 | $4.73M | Buy |
575,046
+161,982
| +39% | +$1.38M | ﹤0.01% | 2833 |
|
|
2021
Q1 | $3.7M | Buy |
413,064
+165,483
| +67% | +$1.9M | ﹤0.01% | 2914 |
|
|
2020
Q4 | $2.86M | Buy |
247,581
+187,542
| +312% | +$2.18M | ﹤0.01% | 2940 |
|
|
2020
Q3 | $625 | Buy |
+60,039
| New | +$736K | ﹤0.01% | 3457 |
|
|
2020
Q1 | – | Sell |
-108,072
| Closed | -$2.24M | – | 4765 |
|
|
2019
Q4 | $2.24M | Buy |
108,072
+97,228
| +897% | +$1.64M | ﹤0.01% | 2553 |
|
|
2019
Q3 | $148K | Buy |
+10,844
| New | +$129K | ﹤0.01% | 3878 |
|
|
2018
Q4 | – | Sell |
-38,401
| Closed | -$718K | – | 4359 |
|
|
2018
Q3 | $718K | Buy |
+38,401
| New | +$882K | ﹤0.01% | 3047 |
|
|
2018
Q2 | – | Sell |
-692,154
| Closed | -$18M | – | 4333 |
|
|
2018
Q1 | $15.5M | Buy |
+692,154
| New | +$16.9M | 0.02% | 1036 |
|
|
2017
Q1 | – | Sell |
-44,804
| Closed | -$852K | – | 3978 |
|
|
2016
Q4 | $852K | Buy |
+44,804
| New | +$856K | ﹤0.01% | 2342 |
|
|
2016
Q3 | – | Sell |
-26,028
| Closed | -$390K | – | 3738 |
|
|
2016
Q2 | $390K | Sell |
26,028
-99,386
| -79% | -$1.25M | ﹤0.01% | 2605 |
|
|
2016
Q1 | $1.15M | Buy |
+125,414
| New | +$1.52M | ﹤0.01% | 2106 |
|
|
2015
Q4 | – | Sell |
-19,840
| Closed | -$295K | – | 3890 |
|
|
2015
Q3 | $295K | Buy |
19,840
+4,154
| +26% | +$97.4K | ﹤0.01% | 2923 |
|
|
2015
Q2 | $343K | Sell |
15,686
-9,178
| -37% | -$185K | ﹤0.01% | 2818 |
|
|
2015
Q1 | $560K | Buy |
+24,864
| New | +$576K | ﹤0.01% | 2680 |
|
Israel Englander's FLXN Position: Q4 2021 in Review
Israel Englander sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 777,952 shares — an estimated $4.75M sold.
Israel Englander first reported a position in FLXN in Q1 2015 and held it in 15 quarters. The position peaked at $15.5M in Q1 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- Israel Englander reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- Israel Englander sold 777,952 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $4.75M.
- Israel Englander first reported a position in Flexion Therapeutics, Inc. in Q1 2015 and held it in 15 quarters.
- Israel Englander's Flexion Therapeutics, Inc. position peaked at $15.5M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.